QurCan Therapeutics Inc.

About:

QurCan Therapeutics (formerly known as Nanology Labs) is a biotech company developing next-generation nanoparticles for gene/chemotherapy.

Website: http://www.qurcan.com

Top Investors: Ontario Centre of Innovation, Creative Destruction Lab (CDL), FACIT, Ontario Brain Institute, Ramen Ventures

Description:

Nanology Labs has designed and is developing Manganescan®, a novel theranostic agent (MRI contrast agent/Radio-sensitizer) that allows detection of brain tumors at early stages using MRI. Simultaneously, it sensitizes cancer cells which improves radiation therapy outcomes. The agent is 3x more sensitive than current Gadolinium contrast agents (GBCAs), can cross the blood brain barrier and enables early and precise detection and targeting of brain cancer.